Line 4: |
Line 4: |
| {{Under Construction}} | | {{Under Construction}} |
| | | |
− | <blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-11-30. The original page can be found at [[HAEM4:Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]]. | + | <blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]]. |
| }}</blockquote> | | }}</blockquote> |
| ==Primary Author(s)*== | | ==Primary Author(s)*== |
Line 14: |
Line 14: |
| ==Cancer Category / Type== | | ==Cancer Category / Type== |
| | | |
− | *[[Mature T- and NK-cell Neoplasms|Mature T- and NK-cell Neoplasm]] | + | *[[HAEM4:Mature T- and NK-cell Neoplasms|Mature T- and NK-cell Neoplasm]] |
| | | |
| ==Cancer Sub-Classification / Subtype== | | ==Cancer Sub-Classification / Subtype== |
| | | |
− | *[[Intestinal T-cell Lymphoma]] | + | *[[HAEM4:Intestinal T-cell Lymphoma]] |
| | | |
| ==Definition / Description of Disease== | | ==Definition / Description of Disease== |
Line 172: |
Line 172: |
| |'''STAT3-JAK2 fusion''' | | |'''STAT3-JAK2 fusion''' |
| |'''Likely role in diagnosis (inclusion)''' | | |'''Likely role in diagnosis (inclusion)''' |
− | |Likely present in CD4+ GI TLPD and absent in [[Enteropathy-Associated T-cell Lymphoma|EATL]], [[Monomorphic Epitheliotropic Intestinal T-cell Lymphoma|MEITL]], and other T-cell lymphomas<ref name=":0" /> | + | |Likely present in CD4+ GI TLPD and absent in [[HAEM5:Enteropathy-associated T-cell lymphoma|EATL]], [[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|MEITL]], and other T-cell lymphomas<ref name=":0" /> |
| |- | | |- |
| |EBV | | |EBV |
Line 429: |
Line 429: |
| ==Links== | | ==Links== |
| | | |
− | *[[Intestinal T-cell Lymphoma]] | + | *[[HAEM4:Intestinal T-cell Lymphoma]] |
| | | |
| ==References== | | ==References== |